Acquired Pelger–Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation
- 1 December 2000
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (11) , 1255-1257
- https://doi.org/10.1038/sj.bmt.1702682
Abstract
A 38-year-old Japanese woman with severe aplastic anemia received an allogeneic bone marrow transplant from her serologically HLA-identical father. Cyclosporine and methotrexate were administered to prevent graft-versus-host disease (GVHD). However, grade III acute GVHD developed on day 44, which was successfully treated with methylprednisolone and tacrolimus. Fluconazole therapy was started for oral candidiasis on day 112, but she complained of headache soon after. In addition to glycosuria and increased serum creatinine levels, Pelger-Huët anomaly of granulocytes was found in her blood, which disappeared after discontinuation of tacrolimus. Transient occurrence of Pelger-Huët cells may be associated with tacrolimus toxicity due to drug interaction with fluconazole.Keywords
This publication has 8 references indexed in Scilit:
- Tacrolimus (FK 506)Annals of Allergy, Asthma & Immunology, 1999
- Association of myelodysplastic changes with purine analoguesBritish Journal of Haematology, 1998
- Association of acquired Pelger‐Huet anomaly with taxoid therapyBritish Journal of Haematology, 1996
- REJECTION AND HEPATITIS IN LIVER TRANSPLANTSTransplantation, 1994
- POSTOPERATIVE GLUCOSE METABOLISM IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- FK506 TROUGH LEVELS IN WHOLE BLOOD AND PLASMA IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993
- Reversible Pseudo-Pelger Anomaly Related to Sulfisoxazole TherapyNew England Journal of Medicine, 1967